Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Goshen. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Goshen at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
The primary objective of Parts 1 and 2 of this study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) of AMG 193 alone and in combination with docetaxel in adult participants with metastatic or locally advanced methylthioadenosine phosphorylase (MTAP)-null solid tumors. The primary objective of Part 3 of this study is to evaluate the efficacy of AMG 193 in adult participants with metastatic or locally advanced MTAP-nul
Sponsor: Amgen
Check if you qualify for this advanced cancer clinical trial in Goshen, IN
If you're searching for advanced cancer treatment options in Goshen, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Goshen research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.